This Toronto father is just 37 and has aggressive cancer. A breakthrough therapy is approved in Canada — but he can't access it
- Posted on July 9, 2026
- By The Toronto Star
- 0 Views
- 1 min read
This Toronto father is just 37 and has aggressive cancer. A breakthrough therapy is approved in Canada — but he can't access it
The tumour-infiltrating lymphocyte therapy uses a patient’s own cells to train their immune system to attack cancer.
